Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1989
Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines
K A Margolin, A A Rayner, M J Hawkins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2006
Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: a Southwest Oncology Group study
H O Smith, C S Jiang, G R Weiss, et al.
Selective Cancer Therapeutics
|
January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule
P W Cobb, K A Havlin, J G Kuhn, et al.
Cancer Research
|
August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule
G S Harman, J B Craig, J G Kuhn, et al.
Cancer Research
|
December 1, 1990
Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule
D D Von Hoff, J G Kuhn, K A Havlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study
K A Margolin, P Y Liu, L E Flaherty, et al.
Cancer Research
|
December 15, 1993
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies
D W Shaffer, L S Smith, H A Burris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077
C D Britten, E K Rowinsky, S D Baker, et al.
Gynecologic Oncology
|
September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)
M L Rothenberg, P Y Liu, S Wilczynski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study
A J Wozniak, J J Crowley, S P Balcerzak, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1989
Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines
K A Margolin, A A Rayner, M J Hawkins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2006
Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: a Southwest Oncology Group study
H O Smith, C S Jiang, G R Weiss, et al.
Selective Cancer Therapeutics
|
January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule
P W Cobb, K A Havlin, J G Kuhn, et al.
Cancer Research
|
August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule
G S Harman, J B Craig, J G Kuhn, et al.
Cancer Research
|
December 1, 1990
Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule
D D Von Hoff, J G Kuhn, K A Havlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study
K A Margolin, P Y Liu, L E Flaherty, et al.
Cancer Research
|
December 15, 1993
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies
D W Shaffer, L S Smith, H A Burris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077
C D Britten, E K Rowinsky, S D Baker, et al.
Gynecologic Oncology
|
September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)
M L Rothenberg, P Y Liu, S Wilczynski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study
A J Wozniak, J J Crowley, S P Balcerzak, et al.
Page
of 10